Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Mol Cancer. 2022 Feb 11;21(1):45. doi: 10.1186/s12943-022-01515-x.
Mol Cancer. 2022.
PMID: 35148751
Free PMC article.